A new WTW survey reveals that over half of employers exceeded their healthcare budgets in 2024 and expect rising costs to continue, prompting a shift toward cost-containment strategies, vendor ...
UniQure Gene Therapy’s Clinical Trial Results Keep It on Path to Become First Huntington’s Treatment
A uniQure gene therapy slowed progression of Huntington’s disease by 75% after three years, statistically significant clinical trial results the company says will support plans for a regulatory ...
Virtual specialty care platform AmplifyMD, which aims to help hospitals do more with fewer doctors, scored $20 million dollars this Wednesday in a Series B financing round led by Forerunner Ventures.
From left to right: Soumi Saha, senior vice president of government affairs at Premier Inc.; Jennifer Goldsack, founder and CEO of the Digital Medicine Society Hallucinations are a frequent point of ...
The U.S. Food & Drug Administration (FDA) recently removed its Risk Evaluation and Mitigation Strategies (REMS) designation from CAR T immunotherapies. REMS is occasionally applied to drugs with ...
Coronary disease is one of the most significant causes of death among women in the United States; it is responsible for one in every three deaths. Advancing age, along with other contributing factors, ...
AI agents — autonomous, task-specific systems designed to perform functions with little or no human intervention — are gaining traction in the healthcare world. The industry is under massive pressure ...
A subcutaneously injected version of Merck cancer immunotherapy Keytruda is now FDA approved, a regulatory decision that gives patients a less burdensome dosing option and provides the pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback